Get started
Piramal Pharma LimitedPiramal Pharma LimitedPiramal Pharma Limited

Piramal Pharma Limited

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsOptionsETFs

PPLPHARMA chart


Full chart

PPLPHARMA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪269.64 B‬ INR
Dividend yield (indicated)
0.07%
Price to earnings Ratio (TTM)
274.25
Basic EPS (TTM)
0.75 INR
Net income (FY)
‪911.30 M‬ INR
Revenue (FY)
‪91.46 B‬ INR
Shares float
‪619.76 M‬
Beta (1Y)
0.89

Employees


Employees (FY)
‪8.56 K‬
Change (1Y)
+629 +7.93%
Revenue / Employee (1Y)
‪10.68 M‬ INR
Net income / Employee (1Y)
‪106.44 K‬ INR

About Piramal Pharma Limited


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Peter Daniel DeYoung
Website
piramalpharma.com
Headquarters
Mumbai
Founded
2020
ISIN
INE0DK501011
FIGI
BBG012W4NGS9
Piramal Pharma Ltd. engages in development and manufacturing of pharmaceutical products. It offers skin care, vitamins and nutrition, antacids, analgesics, gastro-intestinal, and baby-care. The company was founded on March 4, 20202 and is headquartered in Mumbai, India.

Check out other big names from the same industry as PPLPHARMA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PPLPHARMA news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PPLPHARMA is 200.10 INR — it has decreased by −1.36% in the past 24 hours. Watch Piramal Pharma Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Piramal Pharma Limited stocks are traded under the ticker PPLPHARMA.
PPLPHARMA stock has fallen by −2.60% compared to the previous week, the month change is a 3.84% rise, over the last year Piramal Pharma Limited has showed a −8.73% decrease.
We've gathered analysts' opinions on Piramal Pharma Limited future price: according to them, PPLPHARMA price has a max estimate of 313.00 INR and a min estimate of 230.00 INR. Watch PPLPHARMA chart and read a more detailed Piramal Pharma Limited stock forecast: see what analysts think of Piramal Pharma Limited and suggest that you do with its stocks.
PPLPHARMA reached its all-time high on Nov 6, 2024 with the price of 307.85 INR, and its all-time low was 61.65 INR and was reached on Mar 28, 2023. View more price dynamics on PPLPHARMA chart.
See other stocks reaching their highest and lowest prices.
PPLPHARMA stock is 2.06% volatile and has beta coefficient of 0.89. Track Piramal Pharma Limited stock price on the chart and check out the list of the most volatile stocks — is Piramal Pharma Limited there?
Today Piramal Pharma Limited has the market capitalization of ‪269.64 B‬, it has increased by 1.55% over the last week.
Yes, you can track Piramal Pharma Limited financials in yearly and quarterly reports right on TradingView.
Piramal Pharma Limited is going to release the next earnings report on Oct 23, 2025. Keep track of upcoming events with our Earnings Calendar.
PPLPHARMA earnings for the last quarter are −0.80 INR per share, whereas the estimation was −0.69 INR resulting in a −16.79% surprise. The estimated earnings for the next quarter are 0.16 INR per share. See more details about Piramal Pharma Limited earnings.
Piramal Pharma Limited revenue for the last quarter amounts to ‪19.34 B‬ INR, despite the estimated figure of ‪20.01 B‬ INR. In the next quarter, revenue is expected to reach ‪23.26 B‬ INR.
PPLPHARMA net income for the last quarter is ‪−817.00 M‬ INR, while the quarter before that showed ‪1.53 B‬ INR of net income which accounts for −153.22% change. Track more Piramal Pharma Limited financial stats to get the full picture.
Yes, PPLPHARMA dividends are paid annually. The last dividend per share was 0.14 INR. As of today, Dividend Yield (TTM)% is 0.07%. Tracking Piramal Pharma Limited dividends might help you take more informed decisions.
Piramal Pharma Limited dividend yield was 0.06% in 2024, and payout ratio reached 20.33%. The year before the numbers were 0.09% and 79.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 24, 2025, the company has ‪8.56 K‬ employees. See our rating of the largest employees — is Piramal Pharma Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Piramal Pharma Limited EBITDA is ‪13.47 B‬ INR, and current EBITDA margin is 16.59%. See more stats in Piramal Pharma Limited financial statements.
Like other stocks, PPLPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Piramal Pharma Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Piramal Pharma Limited technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Piramal Pharma Limited stock shows the buy signal. See more of Piramal Pharma Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.